ES2183148T3 - Composiciones oftalmicas que contienen un inhibidor de anhidrasa carbonica y de la goma de xantano. - Google Patents

Composiciones oftalmicas que contienen un inhibidor de anhidrasa carbonica y de la goma de xantano.

Info

Publication number
ES2183148T3
ES2183148T3 ES97911223T ES97911223T ES2183148T3 ES 2183148 T3 ES2183148 T3 ES 2183148T3 ES 97911223 T ES97911223 T ES 97911223T ES 97911223 T ES97911223 T ES 97911223T ES 2183148 T3 ES2183148 T3 ES 2183148T3
Authority
ES
Spain
Prior art keywords
inhibitor
gum
xantano
anhydration
ophthalmic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97911223T
Other languages
English (en)
Inventor
Gilles Chastaing
Bernard Plazonnet
Annouk Rozier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Merck Sharp and Dohme Chibret SAS
Original Assignee
Laboratories Merck Sharp and Dohme Chibret SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Merck Sharp and Dohme Chibret SAS filed Critical Laboratories Merck Sharp and Dohme Chibret SAS
Application granted granted Critical
Publication of ES2183148T3 publication Critical patent/ES2183148T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICIONES OFTALMICAS USADAS PARA TRATAR LA HIPERTENSION OCULAR Y EL GLAUCOMA. ESTAS COMPOSICIONES INCLUYEN UNA SOLUCION HIPOTONICA DE 1,1 A 0,2% (EN PESO) DE GOMA DE XANTANO Y DE 0,5 A 5% (EN PESO) DE UN INHIBIDOR DE ANHIDRASA CARBONICA TOPICA O DE UNA DE SUS SALES OFTALMOLOGICAMENTE ACEPTABLES.
ES97911223T 1996-10-17 1997-10-09 Composiciones oftalmicas que contienen un inhibidor de anhidrasa carbonica y de la goma de xantano. Expired - Lifetime ES2183148T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612658A FR2754712B1 (fr) 1996-10-17 1996-10-17 Compositions ophtalmiques

Publications (1)

Publication Number Publication Date
ES2183148T3 true ES2183148T3 (es) 2003-03-16

Family

ID=9496748

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97911223T Expired - Lifetime ES2183148T3 (es) 1996-10-17 1997-10-09 Composiciones oftalmicas que contienen un inhibidor de anhidrasa carbonica y de la goma de xantano.

Country Status (13)

Country Link
US (1) US6264935B1 (es)
EP (1) EP0932389B1 (es)
JP (1) JP2001508035A (es)
AT (1) ATE223200T1 (es)
AU (1) AU715223B2 (es)
CA (1) CA2269552A1 (es)
DE (1) DE69715228T2 (es)
ES (1) ES2183148T3 (es)
FR (1) FR2754712B1 (es)
HR (1) HRP970552A2 (es)
PE (1) PE106998A1 (es)
WO (1) WO1998017249A1 (es)
ZA (1) ZA979219B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
AU8008300A (en) 1999-11-01 2001-05-14 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
PT1305033E (pt) 2000-07-28 2005-01-31 Alcon Inc Composicoes farmaceuticas que contem tobramicina e goma de xantano
US20040067992A1 (en) * 2001-08-10 2004-04-08 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
KR101067795B1 (ko) * 2002-08-30 2011-09-27 니코메드 게엠베하 알레르기성 비염을 치료하기 위한 사이클레소나이드 및 항히스타민제의 조합물의 용도
PT1572217E (pt) * 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
PL1670482T5 (pl) * 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
JP4948176B2 (ja) * 2004-09-28 2012-06-06 千寿製薬株式会社 キサンタンガムおよびアミノ酸を含有する眼科用組成物
JP4966854B2 (ja) * 2005-07-11 2012-07-04 千寿製薬株式会社 キサンタンガムおよびテルペノイドを含有する点眼剤
AU2006331790A1 (en) * 2005-12-19 2007-07-05 Comentis, Inc. Topical mecamylamine formulations for ocular administration and uses therof
JP5244584B2 (ja) * 2006-03-23 2013-07-24 千寿製薬株式会社 キサンタンガムおよびブドウ糖を含有する眼科用組成物
BRPI0714782A2 (pt) 2006-07-31 2013-07-16 Senju Pharma Co preparaÇço lÍquida aquosa contendo composto de amida
US20110117189A1 (en) * 2008-07-08 2011-05-19 S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. Ophthalmic compositions for treating pathologies of the posterior segment of the eye
CN105960238A (zh) * 2013-11-15 2016-09-21 梯瓦制药工业有限公司 使用拉喹莫德治疗青光眼
ES2954412T3 (es) * 2014-10-20 2023-11-22 Sentiss Pharma Private Ltd Solución oftálmica
IT202000002296A1 (it) * 2020-02-06 2021-08-06 Sifi Spa Formulazioni topiche oftalmiche a base di xantano con ridotta posologia

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US5157044A (en) 1983-02-04 1992-10-20 University Of Iowa Research Foundation Analogs of carbonic anhydrase inhibitors and their use as topical IOP inhibitors
US4863922A (en) 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4876271A (en) 1988-12-20 1989-10-24 Merck & Co., Inc. Substituted thieno[3,2-b]thiophene-2-sulfonamides as topically active carbonic anhydrase inhibitors
US4929549A (en) 1989-02-08 1990-05-29 Merck & Co., Inc. 5-carbamoylthieno[2,3-b]thiophene-2-sulfon-amides as topically active carbonic anhydrase inhibitors
US5120757A (en) 1989-07-31 1992-06-09 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents
FR2657018A1 (fr) 1990-01-12 1991-07-19 Merck Sharp & Dohme Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation.
US5242937A (en) 1990-03-19 1993-09-07 Research Corporation Technologies, Inc. Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
US5055480A (en) 1990-03-19 1991-10-08 Research Corporation Technologies, Inc. Topically active ocular gem-diacylthiadiazole sulfonamide carbonic anhydrase inhibitors
US5059613A (en) 1990-03-19 1991-10-22 Research Corporation Technologies, Inc. Topically active ocular benzothiazole sulfonamide carbonic anhydrase inhibitors
IE911192A1 (en) 1990-04-12 1991-10-23 Merck & Co Inc Substituted aromatic sulfonamides as antiglaucoma agents
CA2040460C (en) 1990-05-01 1997-06-10 Tacey X. Viegas Drug delivery with thermoreversible gels
US5091409A (en) 1990-05-17 1992-02-25 Merck & Co., Inc. 4-alkylamino-6-(C3-5 -hydrocarbyl)thieno[2,3-B]thiopyran-2-sulfonamide-7,7-dioxides
US5093332A (en) 1990-10-01 1992-03-03 Merck & Co., Inc. Substituted thieno(2,3-b)(1,4)thiazine-6-sulfonamides as antiglaucoma agents
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
JPH08501303A (ja) 1992-09-17 1996-02-13 アルコン ラボラトリーズ，インコーポレイテッド 局所用炭酸脱水酵素阻害剤組成物
SE9301877D0 (sv) * 1993-06-02 1993-06-02 Kabi Pharmacia Ab In situ gel for therapeutic use
JP2002521333A (ja) * 1998-07-21 2002-07-16 メルク エンド カムパニー インコーポレーテッド 高眼圧治療用眼薬組成物

Also Published As

Publication number Publication date
EP0932389B1 (en) 2002-09-04
AU715223B2 (en) 2000-01-20
EP0932389A1 (en) 1999-08-04
ZA979219B (en) 1998-07-17
PE106998A1 (es) 1999-01-23
JP2001508035A (ja) 2001-06-19
FR2754712B1 (fr) 1999-09-03
HRP970552A2 (en) 1998-08-31
CA2269552A1 (en) 1998-04-30
DE69715228D1 (de) 2002-10-10
AU4867397A (en) 1998-05-15
ATE223200T1 (de) 2002-09-15
US6264935B1 (en) 2001-07-24
DE69715228T2 (de) 2003-06-05
FR2754712A1 (fr) 1998-04-24
WO1998017249A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
ES2183148T3 (es) Composiciones oftalmicas que contienen un inhibidor de anhidrasa carbonica y de la goma de xantano.
BR9813767A (pt) Processo e composição para tratar glaucoma de glc1a
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
EP1225168A3 (en) Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU2733997A (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
DK0750631T3 (da) Mercaptoacetylamido-1,3,4,5-tetrahydrobenzo[c]azepin-3-ondisulfidderivater som enkephalinase- og ACE-inhibitorer
FI961809A (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
BR9811099A (pt) Inibidores de urocinase
EA200000204A1 (ru) Производные пирролопирролона в качестве ингибиторов эластазы нейтрофилов
AU5355498A (en) 15-fluoro prostaglandins as ocular hypotensives
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
EA200100297A1 (ru) Моногидрат гидробромида элетриптана
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
KR920019348A (ko) 탄산탈수효소 억제제 및 β-아드레날린 길항제의 배합물을 포함하는 안과용 조성물
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
ECSP972285A (es) Composiciones oftalmicas
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
AU2003294405A1 (en) Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
CA2183320A1 (en) Novel Mercaptoacetylamide Disulfide Derivatives Useful as Inhibitors of Enkephalinase and Ace
ES2138362T3 (es) Derivados de citisina con contenido de fosforo.
ES2116522T3 (es) Compuestos citotoxicos.
NO20012328L (no) Fluorerte 3,4-dihydrokinolinderivater anvendt som NOS- inhibitorer